Authors' reply to the comment “High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa”

Mondana H. Ghias, Andrew D. Johnston, Allison J. Kutner, Robert G. Micheletti, H. Dean Hosgood, Steven R. Cohen

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e203-e204
JournalJournal of the American Academy of Dermatology
Issue number4
StatePublished - Apr 2021

ASJC Scopus subject areas

  • Dermatology

Cite this